LVIS Stent Versus Enterprise Stent for the Treatment of Unruptured Intracranial Aneurysms

LVIS Stent Versus Enterprise Stent for the Treatment of Unruptured Intracranial Aneurysms
复制标题

LVIS 支架与 Enterprise 支架治疗未破裂颅内动脉瘤的比较

DOI:
10.1016/j.wneu.2016.04.057
复制
发表时间:
2016-07-01
期刊:
影响因子:
2
通讯作者:
Li, Youxiang
Li, Youxiang
中科院分区:
医学4区
文献类型:
--
作者:
Ge, Huijian;Lv, Xianli;Li, Youxiang

文献摘要

被引文献

相似文献

目的:材料与方法:2014年11月至2015年12月,对190例患者共208个未破裂颅内动脉瘤行LVIS和Enterprise支架辅助弹簧圈栓塞术。回顾性分析了手术相关并发症、临床结局和血管造影结果。结果:共92例患者的96个动脉瘤接受了LVIS支架治疗,98例患者的112个动脉瘤接受了Enterprise支架治疗。LVIS支架组中10.9%的患者发生了手术相关并发症(2起出血事件和8起血栓栓塞事件),而Enterprise支架组中16.3%的患者发生了手术相关并发症(1起出血事件、1起占位效应和14起血栓栓塞事件)。两组之间在血栓栓塞(P = 0.263)、出血并发症(P = 0.611)和有利的临床结局(改良兰金评分为0-2)(P = 0.379)方面无统计学显著差异。LVIS支架组的初始完全闭塞或接近完全闭塞率高于Enterprise支架组(96.9% vs. 88.4%,P = 0.034)。较大的动脉瘤尺寸(P = 0.048)是一个独立的预测程序相关的并发症在单变量analysis.CONCLUSIONS:与企业支架相比,LVIS支架可以实现更大的完全或接近完全闭塞率。LVIS和Enterprise支架之间的手术相关并发症和临床结局无显著差异。
OBJECTIVE: This retrospective study compared clinical and angiographic outcomes between LVIS and Enterprise stents.MATERIALS AND METHODS: From November 2014 to December 2015, total 190 patients with 208 unruptured intracranial aneurysms were coiled assisted by LVIS and Enterprise stents. Procedure-related complications, clinical outcomes, and angiographic results were analyzed retrospectively.RESULTS: A total of 92 patients with 96 aneurysms received LVIS stents and 98 patients with 112 aneurysms were treated with Enterprise stents. Procedure-related complications occurred in 10.9% of patients (2 hemorrhagic events and 8 thromboembolic events) in the LVIS stents group whereas 16.3% (1 hemorrhage, 1 mass effect, and 14 thromboembolic events) in the Enterprise stents group. No statistical significant differences in thromboembolic (P = 0.263), hemorrhagic complications (P = 0.611), and favorable clinical outcomes (modified Rankin Scores of 0-2) (P = 0.379) were found between 2 groups. A greater initial complete or near-complete obliteration was found in the LVIS stents group compared with the Enterprise stents group (96.9% vs. 88.4%, P = 0.034). Larger aneurysm size (P = 0.048) was an independent predictor of procedure-related complications in univariate analysis.CONCLUSIONS: Compared with Enterprise stents, LVIS stents may achieve greater complete or near-complete occlusion rate. There was no significant difference in procedural-related complications and clinical outcomes between LVIS and Enterprise stents.